Skip to content

Bruker BRKR Less: current maturities

Less: current maturities at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's less: current maturities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's less: current maturities?
Bruker (BRKR) reported less: current maturities of $8.4M in Q1 2026.
How has Bruker's less: current maturities changed year-over-year?
Bruker's less: current maturities decreased by 77.7% year-over-year, from $37.7M to $8.4M.
What is the long-term trend for Bruker's less: current maturities?
Over 5 years (2020 to 2025), Bruker's less: current maturities has grown at a 49.8% compound annual growth rate (CAGR), from $2.2M to $16.6M.